Salesforce Inc (CRM) Stock: Rallies as Agentforce ARR Surges Over 240% and Stron...
TLDR Salesforce CRM rallies after Q2 results show strong AI growth and higher guidance. Agentforce ARR jumps over 240% as Salesfor...
CrowdStrike Holdings Inc (CRWD) Stock: Climbs After Strong Q2 Results and $333M...
TLDR CrowdStrike stock jumps after record Q2 results and stronger ARR growth outlook CRWD gains as revenue rises 26% and new ARR r...
Synopsys, Inc. (SNPS) Stock: Drops as Profit Growth and AI Expansion Drive Futur...
TLDR Synopsys posts strong Q3 results as AI demand lifts revenue and profit growth SNPS stock dips after hours despite higher earn...
Duluth Trading (DLTH) Stock: Underwear Line Gains Attention Ahead of Fall Shoppi...
TLDR Underwear Focus Supports Fall Wardrobe Demand First-Layer Products Gain Seasonal Attention Popular Underwear Lines Target Fal...
American Electric Power (AEP) Stock: Data Center Growth Fuels Major Customer Sav...
TLDR Data Center Growth Supports Lower Customer Bills &M Targets $59 Million Rate Reduction in 2027 Data Center Demand Drives Indi...
Market Movers Today: Nvidia (NVDA) Earnings, Inflation Jump, and Meta (META) Leg...
Nvidia earnings awaited as inflation hits 3.7%, Intuit misses forecasts, Meta settles lawsuits, and oil falls below $90. Today's k...
Alibaba (BABA) Stock: Qwen Slashes AI Training Costs by 89% with New Qwen3.8-Fla...
Alibaba (BABA) launches Qwen3.8-Flash AI model with 89% cost reduction and enhanced performance. Qwen3.8-Flash-Next previews upcom...
Meta (META) Stock: How Zuckerberg’s AI Workforce Strategy Crashed and Burned
Meta (META) stock faces scrutiny after leaked Project OT documents show abandoned plans for 60% team cuts due to AI failures and e...
BofA: SpaceX Wireless Expansion Would Lift T-Mobile (TMUS) and Tower Stocks, Not...
Bank of America says SpaceX's wireless ambitions face major obstacles and would likely benefit T-Mobile and tower companies rather...
Revolution Medicines (RVMD) Stock Climbs After Early FDA Green Light for Pancrea...
Revolution Medicines (RVMD) stock gained after the FDA granted early approval to Rasonque for pancreatic cancer, with trial data s...